Evidence map›Paper›PMID 42876396›Full record

ArticleProtein science : a publication of the Protein Society2026

A generalizable method for the purification and biophysical characterization of bacterial membrane receptors.

Federico Bosetto, Maria Zacharopoulou, Mark Bycroft, Monika Kish, Giovanna Zinzalla, Pamela J E Rowling, Stephen H McLaughlin, Jonathan J Phillips, Laura S Itzhaki, Ioanna Mela

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Federico BosettoDepartment of Pharmacology, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-8217-2724
Maria ZacharopoulouDepartment of Pharmacology, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-3660-2797
Mark BycroftDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Monika KishLiving Systems Institute, University of Exeter, Exeter, UK.
Giovanna ZinzallaDepartment of Pharmacology, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-1130-4865
Pamela J E RowlingDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Stephen H McLaughlinMedical Research Council Laboratory of Molecular Biology, Cambridge, UK.ORCID https://orcid.org/0000-0001-9135-6253
Jonathan J PhillipsLiving Systems Institute, University of Exeter, Exeter, UK.
Laura S ItzhakiDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Ioanna MelaDepartment of Pharmacology, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0002-2914-9971

Funding

Cancer Research UKDavid James TrustErnest Oppenheimer FundHuman Frontier Science Program RGP0027/2020Medical Research CouncilNational Biofilms Innovation Centre BB/R012415/1 03PoC20-105Royal Society IES\R2\222107Royal Society IES\R3\223128Royal Society RGS\R1\231266Royal Society URF/R1/221795UK Research and Innovation MR/T02223X/1UK Research and Innovation MR/Z000157/1Wellcome Trust
6 · The paper itself

Abstract

Membrane-embedded bacterial receptors are challenging to express and purify in soluble form, yet their isolated domains are essential tools for structural and ligand-discovery studies. Pseudomonas aeruginosa relies on the TonB-dependent heme receptor HasR for iron acquisition, a process central to its pathogenicity. Here, we report a robust strategy for the recombinant expression, purification, and biophysical characterization of the two soluble HasR domains directly involved in heme uptake: the N-terminal plug and the Secretin/TonB short N-terminal domain. Each domain was expressed individually in Escherichia coli and purified to homogeneity, adopting well-folded conformations as confirmed by circular dichroism, NMR spectroscopy, and mass spectrometry. We then engineered a fusion construct containing both domains and systematically evaluated multiple solubilization tags. A GST-His dual-affinity strategy enabled efficient purification of the construct, whereas His6-tag alone resulted in insoluble protein and HLT-tag fusions suffered from non-specific proteolysis. Biophysical analyses revealed that the Secretin/TonB short N-terminal domain remains stably folded within the fusion construct, while the N-terminal plug domain becomes partially disordered, a finding further supported by hydrogen/deuterium exchange mass spectrometry. Together, these results establish a generalizable workflow for producing soluble receptor domains from membrane proteins and provide validated HasR constructs suitable for downstream ligand-screening applications, including aptamer and nanobody discovery.

Indexed as

Bacterial ProteinsMembrane ProteinsPseudomonas aeruginosaReceptors, Cell SurfaceEscherichia coliProtein DomainsRecombinant Fusion ProteinsBacterial ProteinsMembrane ProteinsReceptors, Cell SurfaceRecombinant Fusion Proteinsbiophysical characterizationHasR receptorHDX‐MSNMRprotein purification

Identifiers

PMID42876396
PMCPMC13670019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.